Qube Research & Technologies (QRT)
TRVI icon

Qube Research & Technologies (QRT)’s Trevi Therapeutics TRVI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Buy
+102,226
New +$1.49M ﹤0.01% 2146
2026
Q1 		– Sell
-22,622
Closed -$283K – 4138
2025
Q4 		$283K Sell
22,622
-629,057
-97% -$7.27M ﹤0.01% 2965
2025
Q3 		$5.96M Buy
651,679
+203,827
+46% +$1.53M 0.01% 1651
2025
Q2 		$2.45M Buy
447,852
+321,623
+255% +$2M ﹤0.01% 2115
2025
Q1 		$794K Buy
+126,229
New +$602K ﹤0.01% 2355

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TRVI Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Trevi Therapeutics (TRVI) in Q2 2026: 102,226 shares worth $1.91M. The stake represents ﹤0.01% of the portfolio and ranks #2146 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in TRVI as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in TRVI in Q1 2025 and has held it in 5 quarters since. The position peaked at $5.96M in Q3 2025. 217 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

  • Qube Research & Technologies (QRT) held 102,226 shares of Trevi Therapeutics worth $1.91M as of Q2 2026.
  • Trevi Therapeutics was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Trevi Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2146 holding.
  • Qube Research & Technologies (QRT) first reported a position in Trevi Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Qube Research & Technologies (QRT)'s Trevi Therapeutics position peaked at $5.96M in Q3 2025.
  • 217 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.